Travere Therapeutics Revenue, Growth & Competitor Profile

DBA Retrophin, Inc.

Company Profile & Annual Report for Travere Therapeutics

Access the complete profile.

Travere Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3611 Valley Centre Dr Suite 300 San Diego, CA 92130

Travere Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Travere Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Travere Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Travere Therapeutics is a publicly traded company on NGM using the ticker symbol RTRX. Detailed information on company financials and operating reports can be found here: NGM: RTRX

Travere Therapeutics Annual Revenue and Growth Rate

Travere Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Travere Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Travere Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
October 7, 2013	40	100%	$25 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Travere Therapeutics is developing and marketing. Travere Therapeutics doesn't have any recent trademark applications, indicating Travere Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TRAVERE TOTALCARE providing medical information, consultancy and advisory services	06/28/2022
IDNEYO pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis	09/28/2021
KYDGRATA pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis	09/28/2021

See all trademarks and details in the Full Report.

Market Share of Travere Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Travere Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Travere Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ILLUMINA	San Diego, CA	100
NEUROCRINE BIOSCIENCES	San Diego, CA	23
SANTARUS	San Diego, CA	16
HALOZYME THERAPEUTICS	San Diego, CA	15
MIRATI THERAPEUTICS	San Diego, CA	12
FATE THERAPEUTICS	San Diego, CA	11

Other Companies at 3611 Valley Centre Dr, San Diego CA

Company	Headquarters	Revenue ($ MM)
AIRGAIN	San Diego, CA	100
HOMEBAY	San Diego, CA	11
DELPHI PRIVATE ADVISORS	San Diego, CA	7

Future Competition: Travere Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Travere Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)